loading page

Caplacizumab Treatment in a Case of Resistant Thrombotic Thrombocytopenic Purpura
  • +2
  • Zarrin Hossein-zadeh,
  • Behnam Rafiee,
  • Bebu Ram,
  • Jonathan Weltz,
  • Mark Friedman
Zarrin Hossein-zadeh
NYU Winthrop Hospital

Corresponding Author:[email protected]

Author Profile
Behnam Rafiee
NYU Winthrop Hospital
Author Profile
Bebu Ram
NYU Winthrop Hospital
Author Profile
Jonathan Weltz
NYU Winthrop Hospital Cancer Care
Author Profile
Mark Friedman
NYU Winthrop Hospital
Author Profile

Abstract

A 27-year-old G2P1 woman, admitted at 37 weeks of gestation after complaints of nausea, vomiting, and vaginal bleeding. An emergent vaginal delivery was performed which was complicated by significant blood loss. Thrombotic thrombocytopenic purpura was thought to be the most probable cause, requiring administration of caplacizumab and daily TPE.